MS
MD icon

Marshall & Sullivan’s Pediatrix Medical MD Stock Holding History

Marshall & Sullivan’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,891
Closed -$41.5K – 75
2025
Q2 		$41.5K Buy
+2,891
New +$39.6K 0.02% 73
2023
Q1 		– Sell
-2,891
Closed -$43K – 58
2022
Q4 		$43K Buy
+2,891
New +$47.2K 0.03% 63
2022
Q3 		– Sell
-2,891
Closed -$60K – 66
2022
Q2 		$60K Buy
+2,891
New +$59K 0.04% 54
2014
Q3 		– Sell
-1,800
Closed -$104K – 54
2014
Q2 		$104K Buy
+1,800
New +$106K 0.17% 40

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Marshall & Sullivan's MD Position: Q3 2025 in Review

Marshall & Sullivan sold out of Pediatrix Medical (MD) in Q3 2025, closing a stake of 2,891 shares — an estimated $41.5K sold.

Marshall & Sullivan first reported a position in MD in Q2 2014 and held it in 4 quarters. The position peaked at $104K in Q2 2014. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.

  • Marshall & Sullivan reported no remaining Pediatrix Medical position as of Q3 2025 after selling out during the quarter.
  • Marshall & Sullivan sold 2,891 Pediatrix Medical shares in Q3 2025, an estimated $41.5K.
  • Marshall & Sullivan first reported a position in Pediatrix Medical in Q2 2014 and held it in 4 quarters.
  • Marshall & Sullivan's Pediatrix Medical position peaked at $104K in Q2 2014.
  • 268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.

Based on Marshall & Sullivan's 13F filing for Q3 2025, filed 15 Oct 2025.